SOX2 expression inhibits terminal epidermal differentiation.
Department of Dermatology, Department of Cellular and Molecular Medicine, UCSD Stem Cell Program, University of California, La Jolla, CA, USA.
Yifang
Y
Chen
Department of Dermatology, Department of Cellular and Molecular Medicine, UCSD Stem Cell Program, University of California, La Jolla, CA, USA.
George L
GL
Sen
D002294:Carcinoma, Squamous Cell / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D002454:Cell Differentiation / Q000235:genetics; D000078404:Epidermal Cells; D004817:Epidermis / Q000378:metabolism*; D020869:Gene Expression Profiling; D006801:Humans; D055748:SOXB1 Transcription Factors / Q000235:genetics / Q000378:metabolism*; D012878:Skin Neoplasms / Q000235:genetics / Q000378:metabolism / Q000473:pathology
C527782:SOX2 protein, human; D055748:SOXB1 Transcription Factors
MAF; SOX2; WNT; ZNF750; cancer; cell migration; epidermal differentiation; epidermis; skin tumor; squamous cell carcinoma; stem cells; tumor initiation